Pharmaceutical Transplant Drug Derived from Mycotoxin Reveals Immunosuppression Power of Mold

What was said

"There's a drug called mycophenolate. The brand name is called CellCept. They utilize a particular drug for kidney transplant patients so that you don't have an organ rejection. Well, that mycophenolate, that's the drug name, derived from mycophenolic acid, which is a mycotoxin itself. That's how powerful these mycotoxins are of causing immunosuppression."

Dr. Kim revealed that the immunosuppressant drug CellCept, commonly prescribed to prevent organ transplant rejection, is derived from mycophenolic acid—a mycotoxin produced by mold. This admission demonstrates the pharmaceutical industry's awareness of mycotoxins' profound immunosuppressive effects, while such toxins are simultaneously dismissed as insignificant environmental exposures by mainstream medicine. The revelation adds credibility to claims that chronic mold exposure causes serious immune dysfunction.